Looking at top Wall Street opinions, Tivity Health, Inc. (NASDAQ: TVTY) has recently made its way into the research list of Craig Hallum – signaling that their analyst’s rating adjustment is noteworthy. This stock was Buy in the eyes of Craig Hallum, as reported on Thursday, April 11th, 2019. Another heavy-hitting research note was published by Chardan Capital Markets on Friday February 1st, 2019, with this firm Reiterated TVTY to an updated rating of Buy. In the past six months and three months of trading, shares of Tivity Health, Inc. (TVTY) have moved by -36.10% and -17.06%, respectively.
Brokerage Updates Related to Tivity Health, Inc. (TVTY) Stock
Not a Single analyst have given underperform rating or sell rating, and 3 have given a rating of Buy or better. Based on the 9 stock market experts following this company, the average 12-month price target is $32.86. Moreover, individual price targets range between $28.00-$40.00. With its recent move to $30.50, we can see that these firms project this stock will loss by -48.94% in one year.
Updates from Tivity Health, Inc. (TVTY) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 3.40% rise since the beginning of the calendar year. A Director at Tivity Health, Inc. (TVTY) bought some of its shares in a transaction that was finalized on Mar 22. Similarly, Keckley Paul H. bought 5,780 shares of the organization’s stock at $17.34 apiece and racked up $100,225 in earnings from the purchase. Now, Keckley Paul H. holds 24,696 shares of the company following the exchange. A Director of the organization named Greczyn Robert J Jr, was engaged in a transaction that occurred on Mar 20 that managed to be worth $99,932 from the purchase of 5,810 common shares at a price of $17.20 per individual share.
Tivity Health, Inc. (NASDAQ:TVTY) Results in the Pipeline
The next scheduled release of financial results for Tivity Health, Inc. will be for the Dec-18 quarter. In the same vein, they expect sales for the quarter to amount to $154.02 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $153.04 million. On average, the analyst projection was calling for $151.47 million. In the preceding quarter, this company’s revenue reached $151.87 million.
Qorvo, Inc. (NASDAQ:QRVO) experienced a gain of 2.51% from the closing price in the previous trading day. That boost the price to $78.31 per share, as observed on December 31st, 1969, at a time when the total trading volume reached 2,119,354 shares of stock – compared to the typical average of 1.16M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $71.48.
Pricing Indications for Qorvo, Inc. (QRVO)
This organization has had a price-to-earnings ratio of 450.06 in the last year. Meanwhile, it gained 70.18 from its observable 50-day simple moving average. Right at this moment, the per-share value is 9.45% higher than the mean per-share price over the last 200 days in the market.
Qorvo, Inc. (NASDAQ:QRVO) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 1 have a Buy rating, 10 have an outperform rating, while 12 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 1 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.60, based on information from Thomson Reuters.
QRVO Stock Value Potential
In trading activity as of late, this stock’s value was 71.53 up from its 200 day moving average, while also 11.98% up when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $59.00-$85.00. The market value for the entire organization reached 9.73B. In the last trading session, the price ended the day at $76.39. The institutional holdings related to this organization account for 0.40%, and the Beta factor is now 0.85. This company’s RSI (Relative Strength Index) managed to hit 74.45.
Qorvo, Inc. (NASDAQ:QRVO) Analyst Points of Focus
Qorvo, Inc. (QRVO) has found itself inside of KeyBanc Capital Markets’s research list, so their analyst rating adjustment is worth taking note of. This stock was upgraded to Overweight, compared to its previous rating of Sector Weight by KeyBanc Capital Markets, as garnered from a news report on Tuesday April 2nd, 2019. An additional helpful research note was sent out by Goldman’s on Thursday March 21st, 2019. The brokerage decided to upgrade QRVO to Buy from its previous rating of Neutral.